BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
13.89
-0.38 (-2.66%)
At close: Jun 5, 2026, 4:00 PM EDT
14.13
+0.24 (1.74%)
After-hours: Jun 5, 2026, 5:55 PM EDT
BrainsWay Revenue
BrainsWay had revenue of $15.53M in the quarter ending March 31, 2026, with 34.63% growth. This brings the company's revenue in the last twelve months to $56.22M, up 29.37% year-over-year. In the year 2025, BrainsWay had annual revenue of $52.23M with 27.33% growth.
Revenue (ttm)
$56.22M
Revenue Growth
+29.37%
P/S Ratio
10.41
Revenue / Employee
$435,814
Employees
129
Market Cap
584.97M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 52.23M | 11.21M | 27.33% |
| Dec 31, 2024 | 41.02M | 9.23M | 29.04% |
| Dec 31, 2023 | 31.79M | 4.61M | 16.96% |
| Dec 31, 2022 | 27.18M | -2.48M | -8.36% |
| Dec 31, 2021 | 29.66M | 7.60M | 34.46% |
| Dec 31, 2020 | 22.06M | -1.04M | -4.52% |
| Dec 31, 2019 | 23.10M | 6.70M | 40.89% |
| Dec 31, 2018 | 16.40M | 5.25M | 47.12% |
| Dec 31, 2017 | 11.15M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tactile Systems Technology | 343.52M |
| OrthoPediatrics | 243.30M |
| Cerus | 216.56M |
| SI-BONE | 206.22M |
| Cytek Biosciences | 204.17M |
| Pacific Biosciences of California | 160.03M |
| Beta Bionics | 110.24M |
| NeuroPace | 99.53M |
BWAY News
- 11 days ago - Brainsway price target raised to $17 from $15 at H.C. Wainwright - TheFly
- 19 days ago - Brainsway announces $1.5M investment in APS Innovations - TheFly
- 19 days ago - BrainsWay Announces Minority-Stake Investment in Hopemark Health - GlobeNewsWire
- 24 days ago - BrainsWay Earnings Call Transcript: Q1 2026 - Transcripts
- 24 days ago - BrainsWay Earnings release: Q1 2026 - Filings
- 24 days ago - Brainsway reports Q1 EPS 6c, consensus 5c - TheFly
- 24 days ago - Brainsway backs FY26 revenue view $66M-$68M, consensus $66.44M - TheFly
- 24 days ago - BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights - GlobeNewsWire